Table 1.
microRNA family | Differentiation (specification) | Proliferation, survival, and apoptosis | Secretion and inflammation | Tumorigenesis | Others |
---|---|---|---|---|---|
miR-17/106 | MSCs (↑Ad, ↑Os) [22, 27] NSCs (↑N, ↓G) [25] HSCs (↑B, ↑Ly, ↑My) [28–30] |
↑HSCs [28–30] | MSCs (↑Gdf6 and etc.) [22] | Lymphoma [28–30] | |
miR-125b | HSCs (↑Ly, ↑My) [35, 36]MSCs (↑Ad, ↑Os) [42] Skin stem cells (↓Epi, ↓Oil, ↓HF) [43] |
↑HSCs [35, 36]↑NSCs [41] ↑Skin stem cells [43] |
HSCs (↓CCL4, ↑NF-κB, ↓TNFAIP3) [37, 39, 40] | Breast cancer [44] Hepatocellular carcinoma [45] Leukemia [46] Skin tumor [47] Stomach adenocarcinoma [48] |
↑HSC engraftment [35, 36] |
miR-181 | HSCs (↑Ly) [51] Myoblasts (↑Muscle) [52] |
↑Beta cells [58] | HSCs (↓IL-1α, ↓c-fos, ↓NF-κB) [40] MSCs (↑IL-6) [53] |
Hepatic cancer stem cells [54] Breast cancer [55] Leukemia [56] |
↑T cell receptor sensitivity [57] ↑Blood-brain barrier destruction [59] |
↑: promotion/positive regulation, ↓: inhibition/negative regulation, Ad: adipocytes, Os: Osteoblasts, N: neurons, G: glial cells, B: B cells, Ly: lymphocytes, My: myeloid cells, Epi: epidermal cells, Oil: oil-gland cells, HF: hair follicle cells